Cui-Gai Bai Selected Research

diethanolamine

12/2019

Design, synthesis and evaluation of novel phenothiazine derivatives as inhibitors of breast cancer stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cui-Gai Bai Research Topics

Disease

4	Leukemia 01/2022 - 03/2016
2	Breast Neoplasms (Breast Cancer) 12/2019 - 04/2016
1	Rheumatoid Arthritis 01/2018
1	Neoplasms (Cancer) 04/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2016

Drug/Important Bio-Agent (IBA)

1	ponatinibIBA 01/2022
1	nilotinib FDA Link 08/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2019
1	diethanolamineIBA 12/2019
1	FlavonoidsIBA 12/2019
1	phenothiazineIBA 12/2019
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	AmidesIBA 01/2018
1	TriazolesIBA 01/2018
1	OxadiazolesIBA 01/2018
1	ProdrugsIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	isothiocyanic acidIBA 01/2018
1	sulforaphaneIBA 04/2016
1	1H-tetrazole (tetrazole)IBA 04/2016
1	Imatinib Mesylate (Gleevec)FDA Link 03/2016
1	1,3,4-oxadiazoleIBA 03/2016
1	Cytostatic AgentsIBA 03/2016